Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

69 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Effects of oral ibandronate administered daily or intermittently on fracture risk in postmenopausal osteoporosis.
Chesnut CH 3rd, Skag A, Christiansen C, Recker R, Stakkestad JA, Hoiseth A, Felsenberg D, Huss H, Gilbride J, Schimmer RC, Delmas PD; Oral Ibandronate Osteoporosis Vertebral Fracture Trial in North America and Europe (BONE). Chesnut CH 3rd, et al. Among authors: huss h. J Bone Miner Res. 2004 Aug;19(8):1241-9. doi: 10.1359/JBMR.040325. Epub 2004 Mar 29. J Bone Miner Res. 2004. PMID: 15231010 Free article. Clinical Trial.
Dose-response study of ibandronate in the treatment of cancer-associated hypercalcaemia.
Ralston SH, Thiébaud D, Herrmann Z, Steinhauer EU, Thürlimann B, Walls J, Lichinitser MR, Rizzoll R, Hagberg H, Huss HJ, Tubiana-Hulin M, Body JJ. Ralston SH, et al. Among authors: huss hj. Br J Cancer. 1997;75(2):295-300. doi: 10.1038/bjc.1997.48. Br J Cancer. 1997. PMID: 9010041 Free PMC article. Clinical Trial.
Serum parathyroid hormone-related protein levels and response to bisphosphonate treatment in hypercalcemia of malignancy.
Rizzoli R, Thiébaud D, Bundred N, Pecherstorfer M, Herrmann Z, Huss HJ, Rückert F, Manegold C, Tubiana-Hulin M, Steinhauer EU, Degardin M, Thürlimann B, Clemens MR, Eghbali H, Body JJ. Rizzoli R, et al. Among authors: huss hj. J Clin Endocrinol Metab. 1999 Oct;84(10):3545-50. doi: 10.1210/jcem.84.10.6026. J Clin Endocrinol Metab. 1999. PMID: 10522993 Clinical Trial.
Randomized phase II trial comparing different doses of the bisphosphonate ibandronate in the treatment of hypercalcemia of malignancy.
Pecherstorfer M, Herrmann Z, Body JJ, Manegold C, Degardin M, Clemens MR, Thürlimann B, Tubiana-Hulin M, Steinhauer EU, van Eijkeren M, Huss HJ, Thiébaud D. Pecherstorfer M, et al. Among authors: huss hj. J Clin Oncol. 1996 Jan;14(1):268-76. doi: 10.1200/JCO.1996.14.1.268. J Clin Oncol. 1996. PMID: 8558208 Clinical Trial.
69 results